Key result
Exogenous ATP infusion abolished postjunctional alpha1-adrenergic (-3% vs -39% for adenosine) and alpha2-adrenergic (-4% vs -40%) vasoconstriction in the human forearm in a dose-dependent manner.
Why the study?
Does exogenous ATP blunt direct postjunctional alpha-adrenergic vasoconstriction in young adults?
Does exogenous ATP blunt direct postjunctional alpha-adrenergic vasoconstriction in young adults?
Exogenous ATP blunts direct postjunctional alpha-adrenergic vasoconstriction in a dose-dependent manner, involving both alpha1- and alpha2-receptor subtypes.
Exogenous ATP abolishes postjunctional α1- and α2-adrenergic vasoconstriction in human forearm; leaves open its contribution to exercise sympatholysis.
Recent evidence suggests that adenosine triphosphate (ATP) can inhibit vasoconstrictor responses to endogenous noradrenaline release via tyramine in the skeletal muscle circulation, similar to what is observed in contracting muscle. Whether this involves direct modulation of postjunctional alpha-adrenoceptor responsiveness, or is selective for alpha(1)- or alpha(2)-receptors remains unclear. Therefore, in Protocol 1, we tested the hypothesis that exogenous ATP can blunt direct postjunctional alpha-adrenergic vasoconstriction in humans. We measured forearm blood flow (FBF; Doppler ultrasound) and calculated the vascular conductance (FVC) responses to local intra-arterial infusions of phenylephrine (alpha(1)-agonist) and dexmedetomidine (alpha(2)-agonist) during moderate rhythmic handgrip exercise (15% maximum voluntary contraction), during a control non-exercise vasodilator condition (adenosine), and during ATP infusion in eight young adults. Forearm hyperaemia was matched across all conditions. Forearm vasoconstrictor responses to direct alpha(1)-receptor stimulation were blunted during exercise versus adenosine (DeltaFVC = -11 +/- 3% versus -39 +/- 5%; P< 0.05), and were abolished during ATP infusion (-3 +/- 2%). Similarly, vasoconstrictor responses to alpha(2)-receptor stimulation were blunted during exercise versus adenosine (-13 +/- 4% versus -40 +/- 8%; P< 0.05), and were abolished during ATP infusion (-4 +/- 4%). In Prototol 2 (n = 10), we tested the hypothesis that graded increases in ATP would reduce alpha(1)-mediated vasoconstriction in a dose-dependent manner compared with vasodilatation evoked via adenosine. Forearm vasoconstrictor responses during low dose adenosine (-38 +/- 3%) and ATP (-33 +/- 2%) were not significantly different from rest (-40 +/- 3%; P> 0.05). In contrast, vasoconstrictor responses during moderate (-22 +/- 6%) and high dose ATP (-8 +/- 5%) were significantly blunted compared with rest, whereas the responses during adenosine became progressively greater (moderate = -48 +/- 4%, P = 0.10; high = -53 +/- 6%, P< 0.05). We conclude that exogenous ATP is capable of blunting direct postjunctional alpha-adrenergic vasoconstriction, that this involves both alpha(1)- and alpha(2)-receptor subtypes, and that this is graded with ATP concentrations. Collectively, these data are consistent with the conceptual framework regarding how muscle blood flow and vascular tone are regulated in contracting muscles of humans.
No takes yet. Share an insight, caveat, or question.
Kirby et al. (2008) studied this question. Exogenous ATP vs. Adenosine and rest was evaluated on Forearm vasoconstrictor responses (change in vascular conductance) to alpha1- and alpha2-receptor stimulation (p=<0.05). Exogenous ATP infusion abolished postjunctional alpha1-adrenergic (-3% vs -39% for adenosine) and alpha2-adrenergic (-4% vs -40%) vasoconstriction in the human forearm in a dose-dependent manner.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: